8WFA image
Deposition Date 2023-09-19
Release Date 2025-03-19
Last Version Date 2025-07-02
Entry Detail
PDB ID:
8WFA
Title:
Cryo-EM structure of the PspCas13b-crRNA-target RNA complex (State 2)
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.13 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:PspCas13b
Chain IDs:A
Chain Length:1094
Number of Molecules:1
Biological Source:Prevotella sp.
Polymer Type:polyribonucleotide
Molecule:crRNA
Chain IDs:B
Chain Length:66
Number of Molecules:1
Biological Source:synthetic construct
Polymer Type:polyribonucleotide
Molecule:target RNA
Chain IDs:C
Chain Length:36
Number of Molecules:1
Biological Source:synthetic construct
Ligand Molecules
Primary Citation
Structural insights into RNA-guided RNA editing by the Cas13b-ADAR2 complex.
Nat.Struct.Mol.Biol. ? ? ? (2025)
PMID: 40217120 DOI: 10.1038/s41594-025-01529-1

Abstact

Cas13 is an RNA-guided RNA endonuclease derived from the type VI CRISPR-Cas system, which has been used in numerous RNA-targeting technologies, such as RNA knockdown, detection and editing. The catalytically inactive Prevotella sp. Cas13b (dPspCas13b) fused to the human adenosine deaminase acting on RNA 2 (ADAR2) deaminase domain can edit adenosine in target transcripts to inosine, in an RNA-editing technology called REPAIR (RNA editing for programmable A-to-I replacement), which has potential for gene therapy. Here we report the cryo-electron microscopy structures of the PspCas13b-guide RNA binary complex, the PspCas13b-guide RNA-target RNA ternary complex and the dPspCas13b-ADAR2-guide RNA-target RNA complex. These structures provide mechanistic insights into RNA cleavage and editing. We applied our structural insights to engineer a compact and efficient dPspCas13b-ADAR2 complex (REPAIR-mini). Overall, our findings advance the understanding of CRISPR-Cas13 effector nucleases and could enable the development of improved RNA-targeting technologies.

Legend

Protein

Chemical

Disease

Primary Citation of related structures